Quantcast

Latest Diabetes Stories

2014-08-05 08:34:48

HCI3's Bridges to Excellence recognition program rewards clinicians who provide quality care to help patients manage chronic conditions AUSTIN, Texas, Aug. 5, 2014 /PRNewswire/ -- To improve care for Texans with diabetes, Superior HealthPlan is partnering with the non-profit Health Care Incentives Improvement Institute's (HCI(3)) Bridges to Excellence (BTE) program. BTE is the nation's most extensive effort to recognize and reward high-performing clinicians, improve patient health...

2014-08-05 08:30:34

LONDON, Aug. 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Glucose Monitoring Device Market to 2019 - Technology Adoption and Increasing Health Awareness Serve as Distinct Regional Growth Drivershttp://www.reportbuyer.com/pharma_healthcare/medical_supplies/hospital_supplies/glucose_monitoring_device_market_2019_technology_adoption_increasing_health_awareness_serve_distinct_regional_growth_drivers.htmlGlucose Monitoring Device Market to 2019 -...

2014-08-04 23:04:31

Prometheon Pharma's NoPricks social media and crowdfunding campaign seeks to raise public awareness for the difficulties of needle injection and engage millions living with diabetes to help bring a revolutionary technology to market. Gainesville, FL (PRWEB) August 04, 2014 A University of Florida biotech spinoff has launched an Indiegogo campaign to raise $1,000,000 to advance development of their groundbreaking needle-free, temperature stable insulin patches. These patches are...

2014-08-04 12:35:31

LONDON, Aug. 4, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Hemoglobin A1c Testing Markets http://www.reportbuyer.com/pharma_healthcare/diagnostics/hemoglobin_a1c_testing_markets.html Hemoglobin A1c (HbA1c) testing is the most recent major technology to have entered the diabetes testing market. As the global prevalence of diabetes mellitus continues to increase rapidly, with more than 366 million diabetics worldwide, hemoglobin A1c testing is now an...

2014-08-04 12:35:07

LONDON, Aug. 4, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: U.S. Glucose Testing Markets http://www.reportbuyer.com/pharma_healthcare/diagnostics/u_s_glucose_testing_markets.html U.S. glucose testing is undergoing a significant transition, driven by new analytical technologies and developments in diabetes treatment. Although the blood glucose testing segment of the in vitro diagnostics (IVD) industry is mature, several segments of the market, such...

2014-08-04 12:34:38

LONDON, Aug. 4, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: World Glucose Self-Testing Markets http://www.reportbuyer.com/pharma_healthcare/diseases/diabetes/world_glucose_self_testing_markets.html The worldwide incidence of diabetes is dramatically increasing, and it is estimated that 439 million people will have developed the disease by 2030. As such, the global market for blood glucose self-testing products is undergoing a significant transition...

2014-08-04 09:15:31

Yale University Preventing weight gain, obesity, and ultimately diabetes could be as simple as keeping a nuclear receptor from being activated in a small part of the brain, according to a new study by Yale School of Medicine researchers. Published in the Aug. 1 issue of The Journal of Clinical Investigation (JCI), the study showed that when the researchers blocked the effects of the nuclear receptor PPARgamma in a small number of brain cells in mice, the animals ate less and became...

2014-08-04 08:29:23

- Combination of linagliptin and metformin significantly reduced blood glucose levels compared with linagliptin alone RIDGEFIELD, Conn. and INDIANAPOLIS, Aug. 4, 2014 /PRNewswire/ -- The U.S. Prescribing Information for Jentadueto® (linagliptin and metformin hydrochloride) tablets now includes clinical trial data that showed linagliptin co-administered with metformin provided statistically significant decreases in blood glucose compared with linagliptin alone in treatment-naive* adults with...

2014-08-04 08:27:45

Access to Apligraf® is Improved for Veterans with Chronic Diabetic Foot Ulcers and Venous Leg Ulcers CANTON, Mass., Aug 4, 2014 /PRNewswire/ -- Organogenesis Inc. announced today that it has been awarded Federal Supply Schedule Contract V797D-30288 with the Department of Veterans Affairs (VA) for Apligraf®, the only product with FDA approval for the treatment of both diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). This five-year contract includes an option to extend its...

2014-08-02 00:21:08

Third product from the BI-Lilly Diabetes alliance to be approved by FDA RIDGEFIELD, Conn., and INDIANAPOLIS, Aug. 1, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved Jardiance® (empagliflozin) tablets as an adjunct to diet and exercise to improve glycemic control, or blood glucose levels, in adults with type 2 diabetes (T2D). JARDIANCE is not for people with type 1...


Latest Diabetes Reference Libraries

Diabetes (journal)
2012-05-12 21:44:48

Diabetes is a peer-reviewed medical journal published since 1952 by the American Diabetes Association. Diabetes is a separate journal from the journal Diabetes Care, which is also published by the ADA. Diabetes covers research about the physiology and pathophysiology of diabetes mellitus, including any aspect of laboratory, animal or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic...

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (3 articles) »
Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'